Armando’s journey with cholangiocarcinoma (CCA), a rare biliary tract cancer, reflects the power of connection and resilience. Throughout his experience, he shared how the support of loved ones brought him strength and peace. His words continue to inspire the cancer community, honoring the courage and spirit he carried into every conversation.

Lisa shares the story of her son Jace, who faced his diagnosis of a rare brain cancer with courage and compassion. His outlook continues to inspire the support Lisa now offers to other families navigating childhood cancer.

For people living with small cell lung cancer (SCLC), treatment decisions often come quickly and carry great importance. Resources like our Doctor Discussion Guide or Maintenance Therapy Fact sheet can help you be informed, active participants in your care journey. 

Discover how advancing HER2 science is reshaping cancer care. By deepening understanding of tumor complexity and leveraging biomarker-driven approaches, we are enabling more precise therapies and driving innovation to improve outcomes for patients with HER2-expressing cancers and other areas of high unmet need.

Extensive-stage small cell lung cancer remains one of the most aggressive and difficult-to-treat cancers, with most patients relapsing within months of initial therapy. Maintenance therapy may turn the period of stability after their first treatment into an opportunity to extend response and delay relapse.

We strive to put patient priorities first in our research, advancing our understanding of sleep conditions and the needs of those with narcolepsy and idiopathic hypersomnia.

Corporate Sustainability and Social Impact, or CSSI, helps us embed the needs of patients, our people, communities, and the planet into how we operate and make decisions. It is a business discipline that supports trust, resilience, and long-term value.

We recognize that living with a complex sleep disorder extends far beyond the core symptoms and profoundly impacts every facet of a person’s life. For years, we have worked to better understand the complex, multifaceted realities faced by individuals living with these often-misunderstood conditions.

Each May, Brain Cancer Awareness Month highlights brain and other central nervous system cancers—some of the most complex and least understood. Despite recent advances, people with rare brain tumors still face delays in diagnosis, limited access to specialized care, and fewer treatment options when time matters most.